Publication: 2263

Publication: 2263

Updated analysis of CALGB 100104: lenalidomide (Len) vs. placebo maintenance therapy after single autologous stem cell transplant (ASCT) for multiple myeloma (MM).

URL

URL

Google Scholar

Citation:: J Clin Oncol vol 33 (suppl) abstr 8523

Meeting Instance:: ASCO 2015
Year:: 2015
Type:: Abstract
Sub type:: Poster Discussion
Funding:: NCTN
Endpoint:: Primary
Analysis:: Long-Term-Followup
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 2660

Program:: OGC
Primary Committee:: Myeloma
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, CA31946, CA33601

Corr. Author:
Authors:: Sarah A. Holstein Kouros Owzar Paul G. Richardson Chen Jiang Craig C. Hofmeister Hani Hassoun David D. Hurd Edward A. Stadtmauer Sergio Giralt Steven M. Devine Vera Hars John Postiglione Daniel J. Weisdorf Ravi Vij Jan S. Moreb Natalie S. Callander Marcelo C. Pasquini Thomas C. Shea Kenneth Anderson Philip L. McCarthy

Networks:: LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-NY016, LAPS-NY158, LAPS-OH007, LAPS-WI013, LAPS-WI020, MN022, NC002, NE003, SCOR

Study: CALGB-100104
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: